In the BioHarmony Drug Report Database
Estetrol
Nextstellis, Drovelis, Lydisilka (estetrol) is a small molecule pharmaceutical. Estetrol was first approved as Nextstellis on 2021-04-15. It has been approved in Europe to treat contraception. Nextstellis’s patent is valid until 2025-03-02 (FDA).
Trade Name
|
Drovelis, Lydisilka |
|---|---|
Common Name
|
estetrol |
ChEMBL ID
|
CHEMBL1230314 |
Indication
|
contraception |
Drug Class
|
Image (chem structure or protein)